{"id":519741,"date":"2026-07-01T10:01:10","date_gmt":"2026-07-01T10:01:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/il\/519741\/"},"modified":"2026-07-01T10:01:10","modified_gmt":"2026-07-01T10:01:10","slug":"israels-health-tech-sector-looks-to-ai-as-medicines-next-frontier-israel-jewish-news","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/il\/519741\/","title":{"rendered":"Israel\u2019s health-tech sector looks to AI as medicine\u2019s next frontier – Israel & Jewish News"},"content":{"rendered":"

(July 1, 2026 \/ JNS)\n <\/p>\n

As Israel continues to navigate nearly three years of war and an increasingly competitive global investment landscape, many of the country\u2019s leading physicians, scientists, entrepreneurs and investors gathered in Jerusalem on June 29-30 with their attention fixed firmly on the next frontier of medicine.<\/p>\n

Artificial intelligence, regenerative medicine and 3D bioprinting dominated discussions during the two-day MIXiii Health-Tech.IL conference, where speakers argued that Israel\u2019s greatest advantage lies not only in technological innovation but also in its ability to rapidly translate research into lifesaving medical advances.<\/p>\n

The annual conference, organized by the Israel Advanced Technology Industries Association (IATI), brought together entrepreneurs, venture capital firms, multinational companies, hospitals, researchers and policymakers from Israel and abroad to explore the future of healthcare. This year\u2019s event placed special emphasis on connecting venture capital with Israeli startups and strengthening international partnerships.<\/p>\n

Opening the conference, chairman Yaacov Michlin, CEO of BioLight Life Sciences, emphasized that investment remains the lifeblood of innovation.<\/p>\n

That message was echoed by Alon Stopel, chairman of the Israel Innovation Authority, who described artificial intelligence as the next accelerator of medical discovery while acknowledging that investment in Israel\u2019s technology sector has declined by approximately 40%.<\/p>\n

Rather than slowing innovation, speakers argued that the challenge is integrating AI throughout the development process\u2014from laboratory research to clinical care\u2014while continuing to attract international investment.<\/p>\n

Rebuilding through bioprinting<\/p>\n

One of the conference\u2019s keynote presentations came from Technion professor Shulamit Levenberg, who offered a glimpse into a future in which damaged human tissue may be rebuilt through advanced bioprinting.<\/p>\n

Her presentation, titled \u201cBioprinting and Prosthetics: Turning Rehabilitation Challenges into a National Innovation Mission,\u201d focused on engineering living tissues that could dramatically improve rehabilitation for patients requiring prosthetic limbs.<\/p>\n

Using sophisticated 3D bioprinting technologies, researchers are working to create combinations of muscle, fat and blood-vessel tissue that more closely replicate the body\u2019s natural structures. Such advances could eventually allow prosthetic devices to integrate more effectively with the human body, improving both mobility and quality of life.<\/p>\n

While much of the technology remains under development, Levenberg described tissue engineering as one of the most promising directions in regenerative medicine, particularly as Israel continues caring for soldiers and civilians recovering from severe injuries.<\/p>\n

Her presentation reflected a recurring conference theme: Challenges created by war are increasingly becoming catalysts for medical innovation.<\/p>\n

Lessons from wartime medicine<\/p>\n

Professor Yoram Weiss, director-general of Hadassah Medical Organization, highlighted how Israel\u2019s healthcare system has adapted during wartime while continuing to invest in long-term medical research.<\/p>\n

Alongside the daily demands of treating trauma patients, Hadassah has continued advancing research partnerships, including stem-cell collaborations with institutions in Berlin, while placing renewed emphasis on infection control and rehabilitation.<\/p>\n

For many participants, the discussion illustrated how Israeli hospitals have become both emergency responders and innovation centers, developing solutions under extraordinary circumstances that may ultimately benefit patients worldwide.<\/p>\n

<\/p>\n

\"Dr.<\/p>\n

Dr. Stephen Klasko delivers a keynote address on the future of medicine and AI, June 30, 2026. Photo by Sharon Altshul.<\/p>\n

Healthcare in 2035<\/p>\n

Perhaps the conference\u2019s most thought-provoking keynote address came from American physician and healthcare innovator Dr. Stephen Klasko, who challenged the audience to imagine medicine in 2035 through a holographic presentation that even envisioned pop star Taylor Swift as U.S. president.<\/p>\n

Drawing comparisons to once-unimaginable changes such as the widespread adoption of seat belts, Klasko argued that healthcare is approaching a similarly dramatic transformation.<\/p>\n

Rather than replacing physicians, he predicted that artificial intelligence will increasingly handle routine analysis and administrative tasks, allowing doctors and nurses to spend more time with patients.<\/p>\n

He envisioned two emerging healthcare roles: clinicians enhanced by AI technology and AI agents designed to help patients achieve their personal health goals.<\/p>\n

Artificial intelligence could prove especially transformative in mental healthcare, where patients often wait months before receiving treatment. AI-powered systems, he said, could triage patients more quickly, enabling clinicians to devote greater attention to those requiring complex care.<\/p>\n

The greatest challenge, Klasko suggested, will not be the technology itself but preparing the workforce as the role of medical professionals evolves.<\/p>\n

Investors remain confident<\/p>\n

Despite ongoing regional instability, international investors attending the conference expressed confidence in Israel\u2019s innovation ecosystem.<\/p>\n

During a panel on European venture capital, participants agreed that Israel continues to earn international respect for both the quality of its scientific research and the resilience of its startup community.<\/p>\n

Jonathan Sinclair, an investor from Toronto attending the conference for the second time, said he was struck by both the pace of innovation and the rapid evolution of artificial intelligence.<\/p>\n

\u201cI\u2019ve been amazed by the technology and the speed at which things are being built,\u201d Sinclair told JNS. \u201cI even sent a note to my kids saying, \u2018You should come.\u2019\u201d<\/p>\n

He noted how dramatically conversations had shifted in just a year.<\/p>\n

\u201cLast year, AI wasn\u2019t pervasive. One year later, it\u2019s everywhere.\u201d<\/p>\n

For Phillip Shum of the Canadian Securities Exchange, the visit marked his first trip to Israel.<\/p>\n

Beyond the conference itself, he found time to explore Jerusalem, describing an evening walk through the Old City and a ride on public transportation back to his hotel among the highlights of his visit.<\/p>\n

<\/p>\n

\"Omer<\/p>\n

Omer Gavish, partner and head of pharmaceuticals and life sciences at PwC Israel, presented IATI\u2019s eighth annual industry report, June 30, 2026. Photo by Sharon Altshul.<\/p>\n

An industry looking ahead<\/p>\n

The conference also featured the release of IATI\u2019s eighth annual industry report, presented by Omer Gavish, head of pharmaceuticals and life sciences at PwC Israel who is the lead author of IATI\u2019s annual life sciences report. <\/p>\n

He said the findings offered a mixed assessment of Israel\u2019s life-sciences sector. Rather than describing the year as \u201cthe good, the bad and the ugly,\u201d Gavish characterized it as \u201cthe good, the bad and the stable.\u201d<\/p>\n

While biotechnology continued to show strength, segments of the medical-device industry declined. Tel Aviv nevertheless maintained its position as Israel\u2019s leading life-sciences hub.<\/p>\n

Karin Mayer Rubinstein, IATI\u2019s CEO and president, acknowledged that the past year had been challenging but remained optimistic about the industry\u2019s future.<\/p>\n

\u201cIt has been a challenging year,\u201d she told JNS. \u201cThe report shows some downside, but this was one of the best MIXiii conferences we\u2019ve had.\u201d<\/p>\n

She pointed to the quality of international speakers and investor participation despite ongoing disruptions to international travel.<\/p>\n

\u201cOur focus this year was investment,\u201d she said. \u201cWe brought some of the best venture capital firms in Israel together with speakers from abroad. Given everything that\u2019s happened, it was a very good start, and we\u2019re already looking forward to next year.\u201d <\/p>\n

Throughout the two-day conference, the halls of the International Convention Center in Jerusalem buzzed with one-on-one business meetings as startups pitched their technologies to prospective investors in both private sessions and organized forums.<\/p>\n

Whether through AI-assisted healthcare, regenerative medicine or technologies yet to be imagined, Israel\u2019s health-tech community believes its next generation of breakthroughs is already taking shape\u2014even amid the uncertainties of war.<\/p>\n","protected":false},"excerpt":{"rendered":"(July 1, 2026 \/ JNS) As Israel continues to navigate nearly three years of war and an increasingly…\n","protected":false},"author":2,"featured_media":519742,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[85,46,43],"class_list":["post-519741","post","type-post","status-publish","format-standard","has-post-thumbnail","category-israel","tag-il","tag-israel","tag-news"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/519741","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=519741"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/519741\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/519742"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=519741"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=519741"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=519741"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}